Helen J Lachmann
Helen J Lachmann
University College London and Royal Free London NHS Foundation Trust
Verified email at ucl.ac.uk
Cited by
Cited by
Natural history and outcome in systemic AA amyloidosis
HJ Lachmann, HJB Goodman, JA Gilbertson, JR Gallimore, CA Sabin, ...
New England Journal of Medicine 356 (23), 2361-2371, 2007
Use of canakinumab in the cryopyrin-associated periodic syndrome
HJ Lachmann, I Kone-Paut, JB Kuemmerle-Deschner, KS Leslie, ...
New England Journal of Medicine 360 (23), 2416-2425, 2009
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ...
Circulation 133 (24), 2404-2412, 2016
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis
HJ Lachmann, DR Booth, SE Booth, A Bybee, JA Gilbertson, JD Gillmore, ...
New England Journal of Medicine 346 (23), 1786-1791, 2002
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
PN Hawkins, HJ Lachmann, E Aganna, MF McDermott
Arthritis & Rheumatism: Official Journal of the American College of …, 2004
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
MB Pepys, J Herbert, WL Hutchinson, GA Tennent, HJ Lachmann, ...
Nature 417 (6886), 254-259, 2002
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
HJ Lachmann, R Gallimore, JD Gillmore, HD Carr‐Smith, AR Bradwell, ...
British journal of haematology 122 (1), 78-84, 2003
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome
PN Hawkins, HJ Lachmann, MF McDermott
New Engl J Med 348 (25), 2583-2584, 2003
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA …
E Aganna, F Martinon, PN Hawkins, JB Ross, DC Swan, DR Booth, ...
Arthritis & Rheumatism 46 (9), 2445-2452, 2002
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
N Ter Haar, H Lachmann, S Özen, P Woo, Y Uziel, C Modesto, ...
Annals of the rheumatic diseases 72 (5), 678-685, 2013
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations
HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ...
Rheumatology 45 (6), 746-750, 2006
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel, SM Banypersad, ...
Circulation 132 (16), 1570-1579, 2015
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
HJ Lachmann, P Lowe, SD Felix, C Rordorf, K Leslie, S Madhoo, ...
Journal of Experimental Medicine 206 (5), 1029-1036, 2009
Native T1 mapping in transthyretin amyloidosis
M Fontana, SM Banypersad, TA Treibel, V Maestrini, DM Sado, SK White, ...
JACC: Cardiovascular Imaging 7 (2), 157-165, 2014
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
AD Wechalekar, HJB Goodman, HJ Lachmann, M Offer, PN Hawkins, ...
Blood 109 (2), 457-464, 2007
T1 mapping and survival in systemic light-chain amyloidosis
SM Banypersad, M Fontana, V Maestrini, DM Sado, G Captur, A Petrie, ...
European heart journal 36 (4), 244-251, 2015
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
CP Venner, T Lane, D Foard, L Rannigan, SDJ Gibbs, JH Pinney, ...
Blood, The Journal of the American Society of Hematology 119 (19), 4387-4390, 2012
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ...
Science 352 (6292), 2016
Eprodisate for the treatment of renal disease in AA amyloidosis
LM Dember, PN Hawkins, BPC Hazenberg, PD Gorevic, G Merlini, ...
New England Journal of Medicine 356 (23), 2349-2360, 2007
Senile systemic amyloidosis: clinical features at presentation and outcome
JH Pinney, CJ Whelan, A Petrie, J Dungu, SM Banypersad, ...
Journal of the American Heart Association 2 (2), e000098, 2013
The system can't perform the operation now. Try again later.
Articles 1–20